CN Patent

CN112451477B — 包含脱水山梨糖醇酯的药物组合物

Assigned to Alkermes Inc · Expires 2022-12-30 · 3y expired

What this patent protects

本发明涉及一种药物组合物，其包含对抗精神病药物的递送有用的羧酸脱水山梨糖醇酯。

USPTO Abstract

本发明涉及一种药物组合物，其包含对抗精神病药物的递送有用的羧酸脱水山梨糖醇酯。

Drugs covered by this patent

Aristada (ARIPIPRAZOLE LAUROXIL) · Alkermes Inc

Patent Metadata

Patent number: CN112451477B
Jurisdiction: CN
Classification: —
Expires: 2022-12-30
Drug substance claim: No
Drug product claim: No
Assignee: Alkermes Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.